Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
11%

OVERLAP
BY WEIGHT
3

# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
11%
ALSO IN PSIL
PSIL
30
HOLDINGS
27%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus PSIL)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in MEDX
Weight
in PSIL
Overlap
ALKERMES PLC 3.9% 4.7% 3.9%
ABBVIE INC 8.3% 3.6% 3.6%
JOHNSON & JOHNSON 5.6% 3.4% 3.4%
MEDX Overweight Relative to PSIL
ELI LILLY & CO 17.2%
NOVARTIS AG-ADR 7.3%
ASTRAZENECA PLC 5.3%
IONIS PHARMACEUTICALS, INC. 5.2%
BRISTOL-MYERS SQUIBB CO 5.0%
ABBVIE INC 4.6%
AMGEN INC 4.4%
MERCK & CO. INC. 4.0%
ALNYLAM PHARMACEUTICALS INC 3.9%
PFIZER INC 3.4%
MEDX Underweight Relative to PSIL
ATAI LIFE SCIENCES N.V. -12.2%
RELMADA THERAPEUTICS INC -8.4%
SUPERNUS PHARMACEUTICALS INC -7.7%
NEUROCRINE BIOSCIENCES INC -4.5%
ALTO NEUROSCIENCE INC -4.4%
NEURONETICS, INC. -2.0%
INCANNEX HEALTHCARE INC. -1.3%
NUMINUS WELLNESS INC -1.0%
ALKERMES PLC -0.8%
PACIFIC BIOSCIENCES OF CALIF 0.1%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY